ATE398446T1 - Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids - Google Patents

Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids

Info

Publication number
ATE398446T1
ATE398446T1 AT03715908T AT03715908T ATE398446T1 AT E398446 T1 ATE398446 T1 AT E398446T1 AT 03715908 T AT03715908 T AT 03715908T AT 03715908 T AT03715908 T AT 03715908T AT E398446 T1 ATE398446 T1 AT E398446T1
Authority
AT
Austria
Prior art keywords
controlled release
opioid
oral composition
ester
analgesic oral
Prior art date
Application number
AT03715908T
Other languages
English (en)
Inventor
Luboslav Razus
Ondrej Gattnar
Ivan Varga
Mikulas Lehocky
Viera Kormanova
Viera Hubinova
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE398446T1 publication Critical patent/ATE398446T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT03715908T 2002-04-12 2003-04-10 Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids ATE398446T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK501-2002A SK286107B6 (sk) 2002-04-12 2002-04-12 Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy

Publications (1)

Publication Number Publication Date
ATE398446T1 true ATE398446T1 (de) 2008-07-15

Family

ID=29247067

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03715908T ATE398446T1 (de) 2002-04-12 2003-04-10 Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids

Country Status (13)

Country Link
EP (1) EP1494656B1 (de)
AT (1) ATE398446T1 (de)
AU (1) AU2003219641A1 (de)
CZ (1) CZ20041054A3 (de)
DE (1) DE60321672D1 (de)
EA (1) EA006846B1 (de)
GE (1) GEP20063991B (de)
HU (1) HUP0500438A3 (de)
NO (1) NO20044502L (de)
PL (1) PL372698A1 (de)
SK (1) SK286107B6 (de)
UA (1) UA74991C2 (de)
WO (1) WO2003086365A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107857T1 (de) * 1986-06-10 1994-07-15 Euro Celtique Sa Zusammensetzung mit kontrollierter freisetzung von dihydrocodein.
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
ES2374717T3 (es) * 1999-10-29 2012-02-21 Euro-Celtique S.A. Formulaciones de hidrocodona de liberación controlada.
SK285128B6 (sk) * 1999-12-28 2006-07-07 Zentiva, A. S. Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Also Published As

Publication number Publication date
HUP0500438A2 (hu) 2005-08-29
AU2003219641A1 (en) 2003-10-27
NO20044502L (no) 2004-10-26
EP1494656B1 (de) 2008-06-18
EA200401357A1 (ru) 2005-04-28
SK5012002A3 (en) 2003-11-04
WO2003086365A1 (en) 2003-10-23
HUP0500438A3 (en) 2008-03-28
SK286107B6 (sk) 2008-03-05
UA74991C2 (en) 2006-02-15
EA006846B1 (ru) 2006-04-28
DE60321672D1 (de) 2008-07-31
PL372698A1 (en) 2005-07-25
GEP20063991B (en) 2006-12-11
CZ20041054A3 (cs) 2005-01-12
EP1494656A1 (de) 2005-01-12

Similar Documents

Publication Publication Date Title
CA2582150C (en) Modified release ibuprofen dosage form
JP2021505617A5 (de)
HRP20040323C1 (hr) Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance
HRP20050077B1 (hr) Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona
RU2010123282A (ru) Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
WO2014024193A1 (en) Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
WO2003045437A8 (en) Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
JP3874793B2 (ja) イブプロフェンおよびコデイン含有の改良された医薬処方
CA2468703A1 (en) Controlled release polymeric compositions of bone growth promoting compounds
MX2007006635A (es) Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion.
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
CA2583876A1 (en) A transmucosal veterinary composition comprising detomidine
MEP10808A (en) Solid drug for oral use
CA2503361A1 (en) Controlled-release compositions
WO2002024203A3 (en) Controlled release formulations for oral administration
CA2488422A1 (en) Stable solid medicinal ramosetron composition for oral administration
AU2018285927B2 (en) Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders
EP3750538B1 (de) Nicht-hormonelle verfahren zur männlichen kontrazeption enthaltend (r)-silodosin
ATE398446T1 (de) Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids
JP2002537246A5 (de)
RS20060413A (en) Non-disintegrating oral solid composition of high dose of water soluble drugs
Woroń Drug selection in the treatment of breakthrough pain: how the pharmacokinetic profile of drugsis to be translated into clinical practice
WO2007117314A3 (en) Bupropion controlled release formulations and methods of making
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties